Last update :
07/10/2024
Anticancer drug   Rituximab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Mabthera Argentina, Australia, Austria, Belgium, Chile, Colombia, Croatia, Denmark, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Mexico, Morocco, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, Venezuela
Novex Argentina
Reditux Chile, Peru
Rigetuxer Mexico
Rituxan Canada, Japan, United States of America
Rituximab New Zealand
Rixathon Belgium, France, Germany, Great Britain, Spain, Switzerland
Truxima Belgium, Canada, France, Germany, Great Britain, Spain, United States of America
Compatibility   injection   Compatibility : Rituximab              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
Compound Solvent References

  Mentions Légales